Bionoid Pharma, Inc.
BINP · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $2,160 | $2,700 | $16,630 | $13,499 |
| - Cash | $0 | $0 | $0 | $10 |
| + Debt | $16 | $0 | $0 | $155 |
| Enterprise Value | $2,176 | $2,700 | $16,630 | $13,643 |
| Revenue | $0 | $0 | -$21 | $11 |
| % Growth | – | 100% | -290.7% | – |
| Gross Profit | -$173 | -$173 | -$117 | -$163 |
| % Margin | – | – | 559% | -1,487.5% |
| EBITDA | -$37 | -$73 | $563 | -$10 |
| % Margin | – | – | -2,689.1% | -86.9% |
| Net Income | -$210 | -$247 | -$128 | -$184 |
| % Margin | – | – | 611.2% | -1,677.4% |
| EPS Diluted | -0.004 | -0.005 | -0.002 | -0.003 |
| % Growth | 15.2% | -206.7% | 55.9% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |